TRP Tissue Repair Ltd
—Mkt Cap: —P/E: —1d ago
Tissue Repair Ltd, a clinical stage biopharmaceutical company, develops advanced wound healing products for chronic wounds and aesthetic procedure aftercare in Australia. The company utilizes Glucoprime technology, an im…
Industry Peers
Biotechnology$128.87BUSDP/E 29.6
$94.42BUSD
$81.99BUSDP/E 19.1
$53.47BUSDP/E 32.5
$53.22BUSDP/E 31.6
$44.02BUSDP/E 17.8
$42.56BUSDP/E 66.4
$40.57BUSD
$34.45BUSDP/E 30.4
$31.32BUSDP/E 39.3
$24.59BUSD
$23.32BUSDP/E 31.7
$23.26BUSDP/E 29.8
$22.96BUSDP/E 14.0
$22.66BUSD
$21.67BUSD
$15.57BUSDP/E 19.3
$14.91BUSDP/E 17.4
$13.92BUSDP/E 14.7
$13.79BUSDP/E 33.4
Key Statistics
Company
Market Cap—
Enterprise Value254.84K USD
Revenue (TTM)2.07M USD
Gross Profit386.80K USD
Net Income (TTM)-3.71M USD
Revenue/Share0.05 AUD
Last Price—
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees—
CountryAU
SectorHealthcare
IndustryBiotechnology
ISINAU0000180887
Valuation
P/E (Trailing)—
P/E (Forward)-1.06
PEG—
EV/EBITDA-0.07
EV/Revenue0.12
P/S1.72
P/B0.59
EPS (TTM)-0.09
EPS (Forward)-0.08
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin100.00%
Oper. Margin-204.77%
EBITDA Margin-177.95%
Profit Margin-958.01%
ROE-61.11%
ROA-51.84%
Growth
Revenue Growth-19.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-5.19M USD
CapEx (TTM)30.16K USD
FCF Margin-179.49%
FCF Yield—
Net Debt-3.30M USD
Net Debt/EBITDA0.90
Balance Sheet
Debt/Equity—
Current Ratio6.36
Quick Ratio5.74
Book Value/Sh0.14 AUD
Cash/Share0.08 AUD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 AUD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.60.46M
Float34.36M
Insiders55.26%
Institutions0.00%
Technical
SMA 500.0853 AUD
SMA 2000.1397 AUD
Beta0.22
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)40.28K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—